Macular Degeneration Completed Phase 1 Trials for Bevasiranib (DB06642)
Also known as: Macula lutea degeneration / Retinal macula lutea degeneration / Macular luteal degeneration / Degenerative disorder of macula (disorder) / Degeneration macular
| Indication | Status | Phase |
|---|---|---|
| DBCOND0027875 (Macular Degeneration) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00722384 | Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 | Treatment |